|
|
|
|
LEADER |
01000caa a22002652 4500 |
001 |
NLM351933069 |
003 |
DE-627 |
005 |
20240202231923.0 |
007 |
cr uuu---uuuuu |
008 |
231226s2023 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1016/j.clim.2023.109239
|2 doi
|
028 |
5 |
2 |
|a pubmed24n1278.xml
|
035 |
|
|
|a (DE-627)NLM351933069
|
035 |
|
|
|a (NLM)36682593
|
035 |
|
|
|a (PII)S1521-6616(23)00018-9
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Alduraibi, Fatima K
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Interrelation of T cell cytokines and autoantibodies in systemic lupus erythematosus
|b A cross-sectional study
|
264 |
|
1 |
|c 2023
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 14.02.2023
|
500 |
|
|
|a Date Revised 02.02.2024
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a Published by Elsevier Inc.
|
520 |
|
|
|a T-helper cytokines interferon gamma (IFNɣ), interleukin 17 (IL-17) and IL-10 impact systemic lupus erythematosus (SLE) directly and indirectly via modulation of autoAb production. We determined the separate and combined effects on clinical manifestations of SLE (N = 62). IFNɣ, IL-17 but not IL-10 were significantly elevated in patients with SLE. IFNɣ positively correlated with anti-DNA and anti-SSA. IL-17 positively correlated with anti-SSA and was significantly higher in patients with discoid rash and class V LN. IL-10 did not correlate with circulating autoantibodies but was significantly elevated in patients with LN. Patients with LN had elevated plasma levels of anti-DNA and anti-Sm/ribonuclear protein (RNP). Anti-Sm/RNP levels were decreased in patients with acute mucocutaneous manifestations, including photosensitivity and/or malar rash. The study provides critical insights into pathological mechanisms of LN, which could help guide future diagnoses and therapies
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Research Support, N.I.H., Extramural
|
650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
650 |
|
4 |
|a Research Support, U.S. Gov't, Non-P.H.S.
|
650 |
|
4 |
|a Interferon gamma
|
650 |
|
4 |
|a Interleukin 10
|
650 |
|
4 |
|a Interleukin 17
|
650 |
|
4 |
|a Lupus nephritis
|
650 |
|
4 |
|a Systemic lupus erythematosus
|
650 |
|
7 |
|a Cytokines
|2 NLM
|
650 |
|
7 |
|a Interleukin-17
|2 NLM
|
650 |
|
7 |
|a Autoantibodies
|2 NLM
|
650 |
|
7 |
|a Interferon-gamma
|2 NLM
|
650 |
|
7 |
|a 82115-62-6
|2 NLM
|
650 |
|
7 |
|a Antibodies, Antinuclear
|2 NLM
|
700 |
1 |
|
|a Sullivan, Kathryn A
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Chatham, W Winn
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Hsu, Hui-Chen
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Mountz, John D
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 247(2023) vom: 01. Feb., Seite 109239
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
773 |
1 |
8 |
|g volume:247
|g year:2023
|g day:01
|g month:02
|g pages:109239
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2023.109239
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_11
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 247
|j 2023
|b 01
|c 02
|h 109239
|